Examkin

Question

Difficulty: MediumGynecologic Infections

An asymptomatic 26-year-old pregnant woman, gravida 2, para 1, is evaluated at the clinic during her 10th week of gestation for a routine prenatal visit. Her medical history is unremarkable, and her prior pregnancy ended in an uncomplicated full-term vaginal delivery. The patient reports no pelvic pain, dysuria, vaginal itching, or abnormal discharge. Vital signs are within normal limits. During a speculum examination performed for routine cervical cancer screening, a scant amount of thin, homogeneous, grayish fluid is noted in the vaginal vault. Point-of-care testing of the fluid reveals a pH of 5.0. Microscopic evaluation of a wet mount preparation demonstrates rare leukocytes and multiple squamous epithelial cells studded with coccobacilli that obscure the cell borders. An amine odor is appreciated upon the addition of 10% potassium hydroxide to the sample. Which of the following is the most appropriate next step in the management of this patient?

  1. No further evaluation or treatment is indicatedAnswer
  2. B
    Administration of a 7-day course of oral metronidazole
  3. C
    Administration of a 7-day course of vaginal clindamycin
  4. D
    Administration of single-dose intramuscular ceftriaxone
  5. E
    Performance of a vaginal fluid culture for Gardnerella vaginalis

Answer

No further evaluation or treatment is indicated
The correct answer is no further evaluation or treatment is indicated. This patient presents with clinical and microscopic findings diagnostic of bacterial vaginosis (BV), including a thin, homogeneous, grayish discharge, an elevated vaginal pH of 5.0, the presence of clue cells, and a positive amine 'whiff' test. These findings satisfy the Amsel criteria. However, it is critical to note that this patient is completely asymptomatic and at low risk for preterm delivery, given her history of an uncomplicated full-term vaginal delivery. According to the United States Preventive Services Task Force (USPSTF) and the American College of Obstetricians and Gynecologists (ACOG), routine screening and treatment of asymptomatic BV in pregnant women is not recommended. Large randomized controlled trials have demonstrated that treating asymptomatic BV in women at low risk for preterm delivery does not significantly reduce the incidence of preterm birth, premature rupture of membranes, or other adverse perinatal outcomes. Therefore, initiating antibiotic therapy would violate principles of antimicrobial stewardship and unnecessarily expose the patient to potential medication side effects. Reassurance and routine prenatal observation constitute the standard of care.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and obstetric history.
The patient is asymptomatic, pregnant at 10 weeks gestation, and has a history of a normal term delivery, placing her at low risk for preterm birth.
Risk stratification is essential because it determines the necessity of screening and treating vaginal infections during pregnancy.
2
Interpret the vaginal fluid findings (pH 5.0, clue cells, positive whiff test, homogeneous grayish fluid).
These findings meet Amsel criteria, confirming a diagnosis of bacterial vaginosis (BV).
Accurate diagnosis based on objective criteria is required before considering therapeutic options.
3
Determine the indication for treatment of bacterial vaginosis in this specific patient context.
Treatment is not indicated because the patient is asymptomatic and lacks a history of spontaneous preterm birth.
Current guidelines recommend against treating asymptomatic BV in low-risk pregnancies, as treatment does not prevent preterm delivery or improve maternal-fetal outcomes.

Key Concept

Asymptomatic bacterial vaginosis in pregnant women at low risk for preterm delivery does not require treatment, as pharmacologic intervention does not improve perinatal outcomes.
Estimated Time:1m 0s
Rate this question

Topics

Gynecologic Infections

More questions from this topic